Clinical trials
Phase 1/2 Skin Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 9 |
| Recruiting | 6 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| 7 Hills Pharma, LLC | 1 |
| Allarity Therapeutics | 1 |
| Aprea Therapeutics | 1 |
| Ascend Biopharmaceuticals Ltd | 1 |
| Bruce Robinson, MD | 1 |
| Dynavax Technologies Corporation | 1 |
| Exicure, Inc. | 1 |
| Filamon LTD | 1 |
| Hadassah Medical Organization | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Skin Neoplasms | 35 |
| Melanoma | 20 |
| Neoplasms | 11 |
| Basal Cell Carcinoma | 6 |
| Lung Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Ovarian Neoplasms | 5 |
| Neoplasm Metastasis | 4 |
| Pancreatic Neoplasms | 4 |
| Prostatic Neoplasms | 4 |
Trials
Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.